Core Viewpoint - Wohl & Fruchter LLP is investigating the fairness of the proposed sale of Vital Energy, Inc. to Crescent Energy Company, as the exchange ratio appears to undervalue Vital shares significantly compared to their recent trading history [1][4][6]. Transaction Details - Vital shareholders will receive 1.9062 shares of Crescent Class A common stock for each share of Vital common stock they own [1][4]. - The implied value of $18.05 per Vital share, based on Crescent's stock price of $9.47, is substantially lower than Vital's 52-week high of $38.02, indicating a potentially opportunistic acquisition [2][5]. Shareholder Sentiment - Several Vital shareholders have expressed dissatisfaction with the proposed exchange ratio, with comments highlighting concerns over value destruction and the fairness of the deal [5][6]. - One investor explicitly stated opposition to the proposal, criticizing the Board of Directors for selling at a low valuation [6]. Investigation Focus - The investigation aims to determine if the Vital Board of Directors acted in the best interests of shareholders and whether the agreed exchange ratio is fair [6].

Core Viewpoint - Wohl & Fruchter LLP is investigating the fairness of the proposed sale of HanesBrands Inc. to Gildan Activewear, as the deal price appears to undervalue HanesBrands shares compared to their recent trading history [1][4]. Summary by Relevant Sections Transaction Details - HanesBrands shareholders will receive 0.102 common shares of Gildan and $0.80 in cash for each share of HanesBrands common stock [4]. - The transaction implies a value of $6.00 per HanesBrands share based on the closing prices on August 11, 2025, which is significantly lower than the 52-week high of $9.10 per share [2][5]. Shareholder Sentiment - Several Hanes shareholders have expressed disappointment regarding the deal price, with comments indicating that the offer is perceived as unfavorable [2][5]. - One investor described the deal as "terrible," while another noted that HanesBrands was showing signs of recovery prior to the announcement [5]. Investigation Purpose - The investigation aims to determine whether the Hanes Board of Directors acted in the best interests of shareholders in approving the merger, including the fairness of the exchange ratio and the completeness of disclosed information [5].

Core Scientific and CoreWeave Merger Investigation - The law firm Wohl & Fruchter LLP is investigating the fairness of the proposed all-stock merger between Core Scientific, Inc. and CoreWeave, where Core Scientific shareholders will receive 0.1235 shares of CoreWeave Class A common stock for each share of Core Scientific they own [1][3] - Since the announcement of the merger, Core Scientific's stock price has decreased by over 25%, dropping from $18.00 per share on July 3, 2025, to $13.48 per share on July 22, 2025 [2][4] - The investigation focuses on whether the Core Scientific Board of Directors acted in the best interests of shareholders in approving the merger, particularly regarding the fairness of the exchange ratio and the disclosure of material information related to the transaction [5]